Listing 1 - 8 of 8 |
Sort by
|
Choose an application
Choose an application
Choose an application
This volume reviews the known neurobiology of depression and combines classic data on antidepressant treatments with modern theory on the physiology of depression. It also discusses novel mechanism of action drugs.
Toxicology. --- Psychopharmacology. --- Neurosciences. --- Pharmacology/Toxicology. --- Neural sciences --- Neurological sciences --- Neuroscience --- Medical sciences --- Nervous system --- Behavioral pharmacology --- Drugs --- Chemotherapy --- Pharmacology --- Psychotropic drugs --- Chemicals --- Medicine --- Poisoning --- Poisons --- Psychotropic effects --- Toxicology --- Pharmacology. --- Drug effects --- Medical pharmacology --- Pharmacy --- Physiological effect --- Antidepressants. --- Depression, Mental --- Chemotherapy.
Choose an application
Choose an application
Antidepressants. --- Antidepressive Agents --- Depression, Mental --- Depressive Disorder --- Drug Therapy --- Therapeutic use. --- Chemotherapy. --- Drug therapy. --- Trends.
Choose an application
This new book reviews clinical trial methodology as it pertains to drug development in psychiatry. The authors will describe the process of drug development in psychiatry from discovery through marketing with the help of clinically relevant examples. The history of drug development in psychiatry is explored dating back to the era of serendipitous discovery and culminating in an era of new and highly focused targets. The book will delineate how drug development in psychiatry has changed and adapted with the discovery of drugs with novel mechanisms of action. Drug Development in Psychiatry elucidates how biomarkers, genetics, and advances in neuroscience and neuroimaging have influenced drug development approaches, which will ultimately change the practice of psychiatry. The book charts the early years of drug discovery by chance observation, reviews the developments of the past 50 years of refined targeting of CNS drugs without the discovery of mechanistically new drugs, and looks to the discovery of mechanistically new drugs, the examination of new targets, genetics, and biomarkers.
Neurochemistry. --- Pharmacology. --- Psychiatry. --- Medicine and psychology --- Mental health --- Psychology, Pathological --- Drug effects --- Medical pharmacology --- Medical sciences --- Chemicals --- Chemotherapy --- Drugs --- Pharmacy --- Biochemistry --- Neurosciences --- Physiological effect --- Drug development. --- Psychotropic drugs --- Development
Choose an application
Choose an application
This new book reviews clinical trial methodology as it pertains to drug development in psychiatry. The authors will describe the process of drug development in psychiatry from discovery through marketing with the help of clinically relevant examples. The history of drug development in psychiatry is explored dating back to the era of serendipitous discovery and culminating in an era of new and highly focused targets. The book will delineate how drug development in psychiatry has changed and adapted with the discovery of drugs with novel mechanisms of action. Drug Development in Psychiatry elucidates how biomarkers, genetics, and advances in neuroscience and neuroimaging have influenced drug development approaches, which will ultimately change the practice of psychiatry. The book charts the early years of drug discovery by chance observation, reviews the developments of the past 50 years of refined targeting of CNS drugs without the discovery of mechanistically new drugs, and looks to the discovery of mechanistically new drugs, the examination of new targets, genetics, and biomarkers.
General biochemistry --- History of human medicine --- Physiology of nerves and sense organs --- Psychiatry --- psychiatrie --- neurochemie --- farmacologie
Listing 1 - 8 of 8 |
Sort by
|